RADIANT
Live / Registered — Registered (as of 10 Nov 2026)
What this means for you
Registered since 10 Nov 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 10 Nov 2032: the §8 declaration of use).
Record
- Serial number
- 99513112
- Registration number
- 8546114
- Mark type
- Word mark
- Filed
- 24 Nov 2025
- Published for opposition
- 10 Mar 2026
- Registered
- 10 Nov 2026
- Next maintenance filing
- §8 declaration of use, due by 10 Nov 2032 (grace period to 10 May 2033)
- Attorney of record
- David J. Hrina
Goods and services
- Class 005 — Pharmaceuticals: Biological tissue intended for subsequent implantation in the nature of placental tissue as a barrier for the cornea
Owner
- Sequence LifeScience, Inc., San Antonio, TX, US
- Sequence LifeScience, Inc., San Antonio, TX, US
- Sequence LifeScience, Inc., San Antonio, TX, US
Prosecution history
- 10 Nov 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 10 Nov 2026 — REGISTERED-PRINCIPAL REGISTER
- 21 Oct 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 21 Oct 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 14 Oct 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 28 Sept 2026 — USE AMENDMENT FILED
- 28 Sept 2026 — TEAS STATEMENT OF USE RECEIVED
- 05 May 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 10 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Mar 2026 — PUBLISHED FOR OPPOSITION
- 04 Mar 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Feb 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 11 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 11 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 11 Feb 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED